Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying
Completed
ICOS Corporation
Phase 2
2003-02-01
The purposes of this study are to determine whether an experimental drug known as tadalafil
can reduce symptoms of dyspepsia (fullness after eating, inability to finish a regular meal,
bloating, discomfort or pain in the upper abdomen, belching after meals, nausea, vomiting) in
diabetic patients, and/or reduce the amount of time the stomach takes to empty the contents
of a standard meal. The safety of tadalafil given once daily for 8 weeks in this population
will also be studied.
Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying
Completed
Eli Lilly and Company
Phase 2
2003-02-01
The purposes of this study are to determine whether an experimental drug known as tadalafil
can reduce symptoms of dyspepsia (fullness after eating, inability to finish a regular meal,
bloating, discomfort or pain in the upper abdomen, belching after meals, nausea, vomiting) in
diabetic patients, and/or reduce the amount of time the stomach takes to empty the contents
of a standard meal. The safety of tadalafil given once daily for 8 weeks in this population
will also be studied.
Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction
Completed
Pfizer
Phase 2
2005-02-01
Assessment of duration of action, safety & toleration of different formulations and doses of
UK-369,003 and Cialis in patients with male erectile dysfunction. Patients should have
previously been on PDE5 inhibitors and have been respondents to the drug. Duration of
treatment is 4 weeks.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
